ClinicalTrials.Veeva

Menu

The Effect of Isosorbide Diesters Based Moisturizer on Skin Health

Integrative Skin Science and Research logo

Integrative Skin Science and Research

Status

Completed

Conditions

Atopic Dermatitis

Treatments

Other: Moisturizer containing Colloidal Oatmeal only
Other: Moisturizer Containing Isosorbide Diesters and Colloidal Oatmeal

Study type

Interventional

Funder types

Industry

Identifiers

NCT04831892
I20-ISO1

Details and patient eligibility

About

The overall objective of this study is to assess how a natural ingredient, isosorbide diesters (IDEAS), works in association with colloidal oatmeal for eczema.

Full description

The topical therapy of eczema largely focuses on the use of topical medications but there is demand for topical moisturizers and ingredients that can reduce the need for topical steroids. The goal of this study is to assess the use of a natural ingredient, isosorbide diesters (IDEAS), for eczema and if it can reduce the need for the use of topical steroids.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women aged 18 or over
  • Subjects with a diagnosis of mild to moderate eczema with a SCORAD between 1-50.

Exclusion criteria

  • Individuals who have a known allergy to isosorbide diesters.
  • Individuals who have solely hand and/or foot eczema without evidence of eczema anywhere else on their body.
  • Individuals who have been on topical calcineurin inhibitors or crisaborole to the predetermined areas within two weeks of initiation of participation or unwilling to undergo a washout period.
  • Subjects with an ongoing secondary infection of the skin.
  • Subjects who are on systemic therapy or who need systemic therapy at the discretion of the investigator. Systemic therapies include cyclosporine, systemic steroids, methotrexate, and dupilumab. Subjects who have been on cyclosporine, systemic steroids, or methotrexate in the month prior to initiation of study intervention or are unwilling to undergo a washout period. Subjects who have been on dupilumab in two months prior to initiation of study intervention or are unwilling to undergo a washout period.
  • Subjects with a diagnosis of Scabies.
  • Pregnant women
  • Prisoners

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

34 participants in 2 patient groups

Moisturizer Containing Isosorbide Diesters and Colloidal Oatmeal
Experimental group
Description:
Topical lotion containing isosorbide diesters and colloidal oatmeal to be applied to the entire body once daily.
Treatment:
Other: Moisturizer Containing Isosorbide Diesters and Colloidal Oatmeal
Moisturizer containing colloidal oatmeal
Active Comparator group
Description:
Topical moisturizer with colloidal oatmeal to be applied to the entire body once daily
Treatment:
Other: Moisturizer containing Colloidal Oatmeal only

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems